This blog will discuss FLT3’s normal function, its implications in myeloid malignancies, and the role of NGS in genetic identification and disease management of patients with FLT3 genetic alterations.
Read articleThis blog will discuss FLT3’s normal function, its implications in myeloid malignancies, and the role of NGS in genetic identification and disease management of patients with FLT3 genetic alterations.
ReadWhile liquid biopsy may present an attractive alternative to a solid biopsy, it also has limitations. Here, we shed light on some advantages, limitations, and future outlook for liquid biopsy in oncology clinical practice.
ReadWith many of our team once being customers themselves, our scientists endeavor to create a portfolio shaped by a genuine understanding of its real-world clinical application. Meet Jackie Chan and Huiyan Jin, two of OGT’s Next Generation Sequencing (NGS) experts.
ReadRich and Tori explain how their combined 40 years of experience in clinical diagnostics has been invaluable in helping them to support their customers.
ReadFind out about the benefits and differentiating factors of the three most commonly used NGS technologies; targeted gene panels, whole-exome sequencing (WES) and whole-genome sequencing (WGS).
ReadFind out how OGT's European Field Application Specialists have been finding resourceful ways to support customers during the COVID shutdown.
ReadFind out how OGT's North American Field Application Scientists have been finding resourceful ways to support customers during the COVID shutdown.
ReadCarmen Vokaty, Assistant-Chief Medical Technologist in Cytogenetics at the McGill University Health Centre, details how her lab incorporated OGT’s Cytocell Tissue Pretreatment kit into its workflow after struggling with a homebrew solution.
ReadDr Jennie Thurston, Director of Cytogenetics, Carolinas Pathology Group, Atrium Health, explains how Oxford Gene Technology’s CytoCell FISH probes were seamlessly incorporated into the automated workflow for fast, high quality results.
ReadNext generation sequencing (NGS) is now in routine use for a broad range of research and clinical applications. Facilitating the detection of a wide variety of mutations, focus has never been higher on the value of making the correct choice for the initial sequence enrichment step, which, if poorly designed, can be a source of bias and error in the downstream sequencing assay.
ReadOGT offers unparalled technical support for FISH. Learn more about how Gothami Fonseka, CytoCell FISH Field Application Specialist, works with customers, and what is the first thing she might check for on a troubleshooting call.
ReadOGT offers unparalleled technical support for FISH. Learn more about how Ashley Hart, CytoCell Field Application Scientist, works with customers, and what is the first thing she might check for on a troubleshooting call.
Read
